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Background: Residual untreated atherosclerotic disease after successful percutaneous coronary intervention (PCI) may predispose to future 
adverse events. Compared with other imaging modalities such as intravascular ultrasound (IVUS), angiography may underestimate the presence and 
severity of coronary artery disease.
Methods: In the PROSPECT study, following successful PCI of all clinically significant lesions in patients (pts) with acute coronary syndromes, 
virtual histology (VH)-IVUS was performed in the proximal 6-8cm of all 3 coronary arteries. IVUS analysis was performed off-line and was not used for 
procedural guidance. All pts were followed for at least 2 years.
Results: Of 660 pts with analyzable IVUS, at least one residual high-grade (HG) IVUS-lesion (defined as a minimum luminal area ≤4.0 mm2) was 
found in 366 (55%) pts (mean 1.7 ± 1.0 HG lesions per pt, range 1- 6 lesions). Pts with HG lesions after PCI were more likely women than men 
(64% vs 53%, P=0.01), had a higher prevalence of prior known CAD (16.0% vs 9.9%, P=0.02), a lower creatinine clearance (median 93.4 vs 104.4 
ml/min, P=0.0002), and more angiographic 3-vessel disease (39.4% vs 19.5%, P<0.0001) at the time of PCI. The proportion of plaque which was 
necrotic core by VH was higher in pts with vs. without HG lesions (12.1% vs 10.9%, P=0.009). Thin-capped fibroatheromas (1.18±1.44 vs 0.91±1.28 
per pt, P=0.006) and any fibroatheromas (3.23±1.98 vs 2.39±1.73 per pt, P<0.001) were also more frequent in pts with HG lesions. At the site of 
the minimal luminal area, percent plaque burden and necrotic core were greater in pts with HG lesions (57.3% vs 53.1%, P<0.0001 and 12.1% vs 
10.9%, P=0.009, respectively). At clinical follow up (median 3.4 years), pts with compared to those without HG lesions had greater rates of all-cause 
death (4.7% vs 1.5%, P=0.02), rehospitalization for angina (17.3% vs 11.6%, P=0.009), and revascularization (16.5% vs 12.6%, P=0.04) due to non 
culprit lesions.
Conclusions: After successful PCI of all angiographically significant lesions, residual HG atherosclerotic lesions are frequently present in the 
proximal-mid coronary tree, and predispose to future major adverse cardiovascular events. 
